Navidea Biopharmaceuticals, Inc. (NAVB)
OTCMKTS: NAVB · Delayed Price · USD
0.0370
+0.0002 (0.54%)
Apr 24, 2024, 9:35 AM EDT - Market open
NAVB Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Year | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 - 1992 |
---|---|---|---|---|---|---|---|---|---|---|---|
Cash & Equivalents | 2 | 4.23 | 2.67 | 1.05 | 3.48 | 4.59 | 1.54 | 7.17 | 5.48 | 32.94 | Upgrade
|
Short-Term Investments | 0 | 0 | 0 | 0 | 0.8 | 1.8 | 0 | 0 | 0 | 0 | Upgrade
|
Cash & Cash Equivalents | 2 | 4.23 | 2.67 | 1.05 | 4.28 | 4.59 | 1.54 | 7.17 | 5.48 | 32.94 | Upgrade
|
Cash Growth | -52.83% | 58.43% | 155.02% | -75.51% | -6.91% | 198.35% | -78.52% | 30.79% | -83.37% | 261.23% | Upgrade
|
Receivables | 0 | 0.09 | 2.99 | 0.9 | 0.02 | 8.14 | 1.8 | 3.7 | 0.82 | 1.15 | Upgrade
|
Inventory | 0.43 | 0.15 | 0.17 | -0.9 | 0 | 0 | 1.47 | 0.65 | 0.93 | 2.23 | Upgrade
|
Other Current Assets | 0.78 | 0.91 | 0.7 | 1.87 | 0.68 | -0.7 | 6.01 | 1.05 | 1.37 | 1.01 | Upgrade
|
Total Current Assets | 3.2 | 5.38 | 6.53 | 2.92 | 4.97 | 13.83 | 10.83 | 12.58 | 8.6 | 37.33 | Upgrade
|
Property, Plant & Equipment | 0.16 | 0.25 | 0.38 | 0.31 | 0.16 | 0.24 | 1.25 | 1.93 | 2.51 | 2.13 | Upgrade
|
Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.24 | 0 | Upgrade
|
Intangible Assets | 1 | 0.79 | 0.62 | 0.39 | 0.43 | 0.46 | 0.18 | 0.19 | 0.18 | 0.14 | Upgrade
|
Other Long-Term Assets | 0.01 | 0.23 | 0.23 | 0.54 | 1.44 | 6.25 | 0.2 | 0.27 | 0.39 | 0.72 | Upgrade
|
Total Long-Term Assets | 1.17 | 1.26 | 1.23 | 1.24 | 2.03 | 6.95 | 1.64 | 2.39 | 3.32 | 2.99 | Upgrade
|
Total Assets | 4.37 | 6.64 | 7.76 | 4.15 | 7.01 | 20.78 | 12.46 | 14.96 | 11.92 | 40.32 | Upgrade
|
Accounts Payable | 2.12 | 1.42 | 1.16 | 1.11 | 0.42 | 0.86 | 7.12 | 1.77 | 1.48 | 2.42 | Upgrade
|
Deferred Revenue | 0.8 | 0.7 | 0.7 | 0.7 | 0.87 | -0.86 | 2.32 | 1.04 | -1.48 | -2.42 | Upgrade
|
Current Debt | 0.56 | 0.73 | 1.04 | 0.56 | 0.32 | 2.35 | 51.96 | 0.33 | 4.38 | 4.1 | Upgrade
|
Other Current Liabilities | 6.46 | 2.45 | 1.81 | 1.45 | 1.77 | 5.71 | 8.47 | 3.04 | 4.71 | 7.2 | Upgrade
|
Total Current Liabilities | 9.94 | 5.3 | 4.72 | 3.82 | 3.38 | 8.07 | 69.86 | 6.18 | 9.1 | 11.29 | Upgrade
|
Long-Term Debt | 1.87 | 0.02 | 0.3 | 0.51 | 0.47 | 588.09 | 9.64 | 60.75 | 29.54 | 23.57 | Upgrade
|
Other Long-Term Liabilities | 0.7 | 0.7 | 0.7 | 0.7 | 0.76 | -587.43 | 0.62 | 1.87 | 3.09 | 9.46 | Upgrade
|
Total Long-Term Liabilities | 2.57 | 0.72 | 1 | 1.21 | 1.23 | 0.66 | 10.27 | 62.62 | 32.63 | 33.04 | Upgrade
|
Total Liabilities | 12.51 | 6.02 | 5.71 | 5.03 | 4.61 | 8.73 | 80.13 | 68.8 | 41.72 | 44.33 | Upgrade
|
Total Debt | 2.43 | 0.75 | 1.34 | 1.07 | 0.32 | 2.35 | 61.6 | 61.08 | 33.92 | 27.67 | Upgrade
|
Debt Growth | 224.82% | -43.92% | 25.03% | 238.17% | -86.57% | -96.18% | 0.85% | 80.05% | 22.60% | 185.63% | Upgrade
|
Common Stock | 0.22 | 0.22 | 0.22 | 0.21 | 0.2 | 0.16 | 0.16 | 0.16 | 0.15 | 0.14 | Upgrade
|
Retained Earnings | -388 | -370.79 | -359.06 | -347.67 | -336.72 | -319.91 | -394.86 | -380.55 | -352.98 | -317.26 | Upgrade
|
Comprehensive Income | 0 | 0 | -4.97 | 0 | -0 | -0 | -2.33 | -1.94 | -1.61 | -1.48 | Upgrade
|
Shareholders' Equity | -8.44 | -0.11 | 1.32 | -1.61 | 1.73 | 11.38 | -68.14 | -54.31 | -29.8 | -4.01 | Upgrade
|
Total Liabilities and Equity | 4.37 | 6.64 | 7.76 | 4.15 | 7.01 | 20.78 | 12.46 | 14.96 | 11.92 | 40.32 | Upgrade
|
Net Cash / Debt | -0.44 | 3.48 | 1.33 | -0.02 | 3.96 | 4.04 | -60.06 | -53.91 | -28.44 | 5.27 | Upgrade
|
Net Cash / Debt Growth | - | 160.96% | - | - | -1.92% | - | - | - | - | - | Upgrade
|
Net Cash Per Share | -0.01 | 0.12 | 0.06 | -0.00 | 0.46 | 0.49 | -7.73 | -7.13 | -3.82 | 0.87 | Upgrade
|
Working Capital | -6.74 | 0.08 | 1.81 | -0.9 | 1.6 | 5.76 | -59.04 | 6.39 | -0.5 | 26.04 | Upgrade
|
Book Value Per Share | -0.29 | -0.00 | 0.06 | -0.11 | 0.20 | 1.41 | -8.77 | -7.18 | -4.01 | -0.66 | Upgrade
|
Sources: The data provider is Financial Modeling Prep and the numbers are sourced from SEC filings.